Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-12-02T21:12:57.608Z Has data issue: false hasContentIssue false
  • English
  • Français

Multidrug Resistant Acinetobacter baumanii: A 15-Year Trend Analysis

Published online by Cambridge University Press:  27 March 2018

Dana L. Russell ,
Daniel Z. Uslan ,
Zachary A. Rubin ,
Tristan R. Grogan  and
Elise M. Martin
Dana L. Russell*
Affiliation:
Ronald Reagan UCLA Department of Clinical Epidemiology and Infection Prevention, Los Angeles, California
Daniel Z. Uslan
Affiliation:
Division of Infectious Diseases, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
Zachary A. Rubin
Affiliation:
Division of Infectious Diseases, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
Tristan R. Grogan
Affiliation:
Department of Medicine Statistics Core, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
Elise M. Martin
Affiliation:
Division of Infectious Diseases, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, California
*
Address correspondence to Dana L. Russell, MPH, CIC, Ronald Reagan UCLA Department of Clinical Epidemiology and Infection Prevention, 924 Westwood Blvd, Suite 900, Los Angeles, CA 90095 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

From 2000 to 2009, rates of multidrug-resistant Acinetobacter baumanii increased 10-fold to 0.2 per 1,000 patient days. From 2010 to 2015, however, rates markedly declined and have stayed below 0.05 per 1,000 patient days. Herein, we present a 15-year trend analysis and discuss interventions that may have led to the decline.

Infect Control Hosp Epidemiol 2018;39:608–611

Type
Concise Communications
Information
Infection Control & Hospital Epidemiology , Volume 39 , Issue 5 , May 2018 , pp. 608 - 611
Copyright
© 2018 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Karageorgopoulos, DE, Falagas, ME. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008;8:751–762.Google Scholar
2. Wendt, C, Dietze, B, Dietz, E, Ruden, H. Survival of A. baumanii on dry surfaces. J Clin Microbiol 1998;35:1394–1397.Google Scholar
3. Gaynes, R, Edwards, JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41:848–854.Google Scholar
4. Cho, OH, Bak, MH, Baek, EH, Park, KH, Kim, S, Bae, IG. Successful control of carbapenem-resistant Acinetobacter baumannii in a Korean university hospital: a 6-year perspective. Am J Infect Control 2014;42:976–979.Google Scholar
5. Hidron, AI, Edwards, JR, Patel, J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007. Infect Control Hosp Epidemiol 2008;29:996–1011.CrossRefGoogle Scholar
6. Sievert, DM, Ricks, P, Edwards, JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Control Hosp Epidemiol 2013;34:1–14.CrossRefGoogle Scholar
7. Antibiotic resistant threats in the United States. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/threat-report-2013/index.html. Published 2013. Accessed November 2017.Google Scholar
8. Weiner, LM, Webb, AK, Limbago, B, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect Control Hosp Epidemiol 2016;37:1288–1301.Google Scholar
9. MDRO and C. difficile infection module. Centers for Disease Control and Prevention National Health Safety Network website. https://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf. Published January 2017. Accessed November 2017.Google Scholar
10. Cheon, S, Kim, M, Yun, S, Moon, JY, Kim, YS. Controlling endemic multidrug-resistant Acinetobacter baumannii in intensive care units using antimicrobial stewardship and infection control. Kor J Intern Med 2016;31:367–374.CrossRefGoogle ScholarPubMed